CLINICAL_TRIALS
trial_result
· 2018-11-09
Clinical Trial Update: Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001) [Phase 1]
Summary
Phase 1 study MK-5108-001 in patients with advanced or refractory solid tumors has completed, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Cancer, Neoplasms, Tumors | Phase 1 | Status: COMPLETED | Results posted: 2018-11-09